Adham Ramadan (@AdhamGR97) header
Adham Ramadan (@AdhamGR97) profile picture

PGY-2 resident @BMCSouthIM @BMC_Brighton| Clinical instructor @BUmedicine | Former Research Fellow @mghcvrc @harvardmed |@alexandriamed alumni

Boston, MA
Joined February 2023
Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)Photo by Adham Ramadan (@AdhamGR97)
Adham Ramadan retweeted
TATUM DUNKED ON LEBRON The camera IMMEDIATELY cut to Jaylen Brown 😭
137
801
178
9,078
744,836
Publication 🚨 We compared semaglutide vs tirzepatide in over 5K matched pairs of adults with obesity and ASCVD without diabetes. I would like to congratulate all the coauthors on their efforts! Shoutout to my partner in crime @MohamedDomaa ! doi.org/10.1016/j.ahjo.2026.…
1
10
391
Had a great time at #TCT2026 in San Diego presenting two studies, LVEF recovery after CTO PCI in ischemic cardiomyopathy and 30 day outcomes after CTO PCI vs non CTO PCI. Grateful to @crfheart for the opportunity and to my co-authors. Looking forward to future meetings!
23
605
Can't wait to meet you all at #TCT2026 in San Diego. Come say hi and let's talk CTO PCI! 30 day outcomes, CTO vs non CTO PCI: sciencedirect.com/science/ar… LVEF recovery after CTO PCI: hmpgloballearningnetwork.com…
1
19
706
Excited to share our new study in @hrs_journal on GLP-1 RAs and SGLT2 inhibitors after AF ablation. AF recurrence was similar, but combination therapy was linked to lower mortality. Thanks to Mohamed, Adham, and our team! #Cardiology #AtrialFibrillation doi.org/10.1016/j.hrthm.2026…
1
7
376
Adham Ramadan retweeted
The Effect of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors Alone and in Combination on AF Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation @AdhamGR97 heartrhythmjournal.com/artic…
7
16
2,008
publication 🚨 We compared GLP-1 RAs and SGLT2i, alone and in combination, for AF recurrence and cardiovascular outcomes after catheter ablation. Proud of this work with an incredible team. @hrs_journal #Cardiology #EPeeps #AFib #GLP1RA #CardioX heartrhythmjournal.com/artic…
1
3
20
684
Grateful to be part of this with an incredible team. Thank you to all co-authors and a special thanks to @michaelmegalymd for his mentorship and guidance. @MyJSCAI #CTOPCI #CardioX
Among the criticisms of #CTO #PCI is the higher risk compared to regular PCI procedures. This perception stems from the procedure's higher complexity. The unmeasured factor is that CTO PCI is usually performed by operators who can identify and treat possible complications faster and have the awareness to prevent problems or manage them. Our study from the National Trinetix database @MyJSCAI, led by @AdhamGR97 and @MohamedDomaa, compared 30-day outcomes between CTO PCI and ELECTIVE (non-MI) non-CTO PCI, and also trended outcomes over three recent periods (2014-2017, 2018-2021, 2022-2025). Our major findings are as follows 1-CTO PCI risk of pericardiocentesis was higher than non-CTO PCI (0.2% vs 0.09%) but remains very small at 0.2% 2-CABG after CTO PCI was higher than non-CTO PCI; we could not determine the cause, but it was mostly related to failure and the need for revascularization rather than complications. Also, the trend of CABG after CTO PCI has been decreasing. 3-Finally, none of this led to adverse outcomes, as there was absolutely no difference in mortality between the two groups. In the hands of experienced operators, CTO PCI can be safe and effective. sciencedirect.com/science/ar… #CardioX #ACCFIT
1
13
1,097
✍️ Authors: Mohamed Doma, @KrityaMangesh, @AdhamGR97, Ibrahim Kamel, @IuriFFelix, Seif Shlkamy, Shanmukh Sai Pavan Lingamsetty, Ahmed K. Mahmoud, @Mahmoud_Ismayl, Ashwin Mahesh, @AGoldsweig
1
2
119
🫀TAVR vs SAVR: who has lower aortic dissection risk? 1️⃣40,000+ matched patients analyzed 2️⃣TAVR showed lower AD risk at 1, 3 & 5 years 3️⃣Lower risk for both Type A & Type B AD TAVR may offer a vascular safety advantage in selected patients.#Cardiology imrpress.com/journal/RCM/27/…
1
9
2
18
3,222
🚨 New paper out in CRM! We examined early pericardial complications after LAAO and their long-term clinical outcomes. 🔗 doi.org/10.1016/j.carrev.202… @CRMjournal @MohamedDomaa @jibran_ikram @AllanLKleinMD1 @AGoldsweig #LAAO #Cardiology #CardioX #MedX
1
2
16
1,095
Adham Ramadan retweeted
Still got the World Cup fever! But #CTO #PCI does not take a day off Our study @InvasiveCardiol led by @AdhamGR97 and @MohamedDomaa investigating the trajectory of LVEF improvement after CTO PCI The two main findings are 1- LVEF recovery occurs across the full baseline EF spectrum, with the greatest magnitude of improvement observed in patients with baseline EF 31–39%. 2-More importantly: Recovery is not a fixed, early-plateau phenomenon; it is progressive over time. In the EF 31–39% cohort, the cumulative probability of EF normalization (>40%) increased incrementally: 26.1% at 6 months 33.5% at 12 months 37.4% at 18 months 39.9% at 24 months This supports a delayed and progressive model of functional recovery post CTO PCI, consistent with the known time course of hibernating myocardium reversal and recovery of regional wall motion extending well beyond the conventional 6-month assessment window. Clinical implication is significant as EF reassessment at 6 months alone may underestimate the true revascularization benefit in CTO patients with reduced LVEF, which was the drawback of randomized trials investigating this outcome. hmpgloballearningnetwork.com… @grego @bdcogar #ACCFIT #CardioX
2
17
1
32
6,954
Honored to receive the Outstanding Internal Medicine Intern award this year. Grateful to my attendings, co-residents, and the entire team for making this year one to remember. On to PGY-2! #MedTwitter #IMResidency #MedEd
2
1
34
1,556
Honored to be voted by faculty as PGY-2 Resident of the Year, and to receive the Best Resident Teacher and Professionalism Awards ! Grateful for the recognition and continued support throughout residency 🙏
13
7
5
451
32,777
Adham Ramadan retweeted
CLASH (Controlled Laceration of Aortic Subintimal Hematoma/Flap) Our technique @JACCJournals can come in handy in situations involving iliac #CTO and retrograde attempts that lead to aortic hematoma formation. After successful crossing from the contralateral iliac, you cannot get the wire to cross into the aorta due to the hematoma. I thought of it on the fly while being in the case, inspired by the coronary CTO SLASH technique. Snaring an antegrade radial wire and pulling it across the aortic hematoma would allow controlled laceration of the hematoma. Eventually leading to success. As usual, credit for the figure drawings goes to my wife @mariamtawadros3 #CardioX #ACCFIT jacc.org/doi/10.1016/j.jcin.…
3
23
95
9,380